International Biotechnology Trust as of June 30, 2020
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 53 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Therapeutics Pub SHS | 8.0 | $24M | 434k | 55.28 | |
| BioMarin Pharmaceutical (BMRN) | 7.5 | $23M | 186k | 122.18 | |
| Gilead Sciences (GILD) | 7.5 | $23M | 303k | 74.57 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 6.1 | $19M | 65k | 285.18 | |
| Immunomedics | 5.1 | $15M | 448k | 34.23 | |
| Ptc Therapeutics I (PTCT) | 5.0 | $15M | 299k | 50.62 | |
| ACADIA Pharmaceuticals (ACAD) | 4.9 | $15M | 305k | 48.19 | |
| Biogen Idec (BIIB) | 4.4 | $13M | 51k | 260.27 | |
| Neurocrine Biosciences (NBIX) | 4.4 | $13M | 106k | 125.50 | |
| Amgen (AMGN) | 4.0 | $12M | 52k | 231.58 | |
| Chemocentryx | 3.5 | $11M | 192k | 54.62 | |
| Exelixis (EXEL) | 3.4 | $10M | 453k | 22.73 | |
| Alexion Pharmaceuticals | 3.3 | $9.8M | 88k | 111.22 | |
| Seattle Genetics | 3.0 | $9.1M | 56k | 164.38 | |
| Incyte Corporation (INCY) | 2.7 | $8.0M | 78k | 102.47 | |
| Halozyme Therapeutics (HALO) | 2.6 | $7.9M | 308k | 25.81 | |
| Regeneron Pharmaceuticals (REGN) | 2.3 | $7.0M | 12k | 610.43 | |
| Myokardia | 2.1 | $6.4M | 66k | 96.75 | |
| Zogenix | 2.1 | $6.2M | 237k | 26.06 | |
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $5.4M | 36k | 147.93 | |
| Mirati Therapeutics | 1.7 | $5.0M | 44k | 114.62 | |
| Sarepta Therapeutics (SRPT) | 1.2 | $3.5M | 22k | 162.74 | |
| Biohaven Pharmaceutical Holding | 1.0 | $3.1M | 45k | 69.31 | |
| Ionis Pharmaceuticals (IONS) | 0.8 | $2.4M | 40k | 59.40 | |
| Enanta Pharmaceuticals (ENTA) | 0.8 | $2.3M | 47k | 49.03 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.2M | 177k | 12.66 | |
| Turning Point Therapeutics I | 0.7 | $2.2M | 35k | 63.89 | |
| Ascendis Pharma AS Sponsored ADR (ASND) | 0.7 | $2.0M | 14k | 144.86 | |
| Acceleron Pharma | 0.6 | $1.7M | 18k | 96.06 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.5 | $1.7M | 22k | 75.05 | |
| Sage Therapeutics (SAGE) | 0.5 | $1.6M | 38k | 41.76 | |
| Immunic (IMUX) | 0.5 | $1.5M | 123k | 12.45 | |
| Nektar Therapeutics (NKTR) | 0.5 | $1.5M | 67k | 22.37 | |
| Amicus Therapeutics (FOLD) | 0.5 | $1.5M | 95k | 15.54 | |
| Principia Biopharma | 0.4 | $1.3M | 23k | 56.19 | |
| Uniqure Nv SHS (QURE) | 0.4 | $1.3M | 28k | 45.71 | |
| GW Pharmaceuticals Ads | 0.4 | $1.2M | 10k | 121.96 | |
| Allakos (ALLK) | 0.4 | $1.1M | 16k | 72.80 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $1.1M | 22k | 52.98 | |
| Sutro Biopharma (STRO) | 0.4 | $1.1M | 139k | 7.87 | |
| Arena Pharmaceuticals | 0.3 | $1.0M | 17k | 62.85 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $994k | 17k | 58.47 | |
| Momenta Pharmaceuticals | 0.3 | $970k | 27k | 35.93 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $920k | 11k | 85.98 | |
| Blueprint Medicines (BPMC) | 0.3 | $918k | 12k | 76.50 | |
| Insmed (INSM) | 0.3 | $902k | 34k | 26.85 | |
| Fibrogen (FGEN) | 0.3 | $799k | 20k | 40.56 | |
| Bluebird Bio (BLUE) | 0.2 | $660k | 11k | 60.00 | |
| Global Blood Therapeutics In | 0.2 | $652k | 9.8k | 66.53 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $579k | 23k | 25.17 | |
| Esperion Therapeutics (ESPR) | 0.2 | $452k | 9.5k | 47.58 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $227k | 10k | 22.70 | |
| Zealand Pharma A S Sponsored Adr | 0.1 | $187k | 5.7k | 33.08 |
